BioCentury
ARTICLE | Clinical News

MDX-1100: Phase II data

May 18, 2009 7:00 AM UTC

Top-line data from a double-blind, European Phase II trial in 70 patients showed that 10 mg/kg MDX-1100 every 2 weeks met the primary endpoint of a significant improvement in ACR20 at week 12 vs. plac...